vimarsana.com
Home
Live Updates
Valneva Vaccinates First Participant in Pediatric Trial of Single-Shot Chikungunya Vaccine : vimarsana.com
Valneva Vaccinates First Participant in Pediatric Trial of Single-Shot Chikungunya Vaccine
Saint-Herblain , January 10, 2024 – Valneva SE today announced that the first participant has been vaccinated in the Phase 2 clinical trial evaluating the safety and Immunogenicity in children of...
Related Keywords
Honduras ,
Dominican Republic ,
Brazil ,
France ,
Canada ,
New York ,
United States ,
Instituto Butantan ,
Joshua Drumm ,
Juan Carlos Jaramillo ,
Vp Global Communications European Investor Relations ,
European Union Horizon ,
Brazilian Health Regulatory Agency Anvisa ,
Health Information For International ,
European Medicines Agency ,
Centers For Disease ,
Oxford University Press ,
Oxford University ,
Health Canada ,
Drug Administration ,
Pfizer ,
Euronext Paris ,
Chief Medical Officer ,
Brazilian Health Regulatory Agency ,
Southeast Asia ,
Middle Income Countries ,
European Union ,
Prescribing Information ,
Reports Positive Pivotal Phase ,
Single Shot Chikungunya Vaccine Candidate ,
First Chikungunya Vaccine ,
Health Information ,
International Travel ,
Disease Control ,
Zine Analytics Chikungunya ,
Cumulative Cases ,
Instituto Butantan Sign Final Agreement ,
Single Shot Chikungunya Vaccine ,
Middle Income ,
Markets ,
vimarsana.com © 2020. All Rights Reserved.